The overall population analysis showed no significant association between RAD51 135G/C polymorphism and risk of SCCHN, colorectal cancer, ovarian cancer and acute leukaemia in any genetic model. This evidence concerns the gene RAD51 and head and neck squamous cell carcinoma.